| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pembrolizumab vs nivolumab mechanism | 1.4 | 0.2 | 1676 | 46 | 36 |
| pembrolizumab | 1.76 | 0.1 | 718 | 76 | 13 |
| vs | 1.25 | 0.7 | 3441 | 77 | 2 |
| nivolumab | 1.81 | 0.8 | 2354 | 62 | 9 |
| mechanism | 0.81 | 0.3 | 614 | 64 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pembrolizumab vs nivolumab mechanism | 1.63 | 0.5 | 2394 | 2 |
| nivolumab and pembrolizumab combination | 1.69 | 0.9 | 3420 | 89 |
| pembrolizumab vs nivolumab melanoma | 1.47 | 0.9 | 1276 | 49 |
| ipilimumab and nivolumab vs pembrolizumab | 1.36 | 0.3 | 7646 | 88 |
| nivolumab pembrolizumab and atezolizumab | 1.18 | 0.7 | 9941 | 43 |
| pembrolizumab versus nivolumab for melanoma | 1.12 | 0.8 | 8495 | 95 |
| pembrolizumab mechanism of action | 1.61 | 0.1 | 2982 | 45 |
| nivolumab and pembrolizumab for lung cancer | 0.41 | 0.3 | 4757 | 5 |
| nivolumab and pembrolizumab side effects | 0.64 | 0.5 | 6167 | 37 |
| pembrolizumab mechanism of action youtube | 0.44 | 0.6 | 7442 | 86 |
| pembrolizumab mechanism of action ppt | 0.92 | 0.8 | 3840 | 35 |
| nivolumab and pembrolizumab for mesothelioma | 0.8 | 0.7 | 5544 | 16 |
| pembrolizumab how it works | 0.16 | 0.5 | 4295 | 48 |
| pembrolizumab target mechanism of action | 0.27 | 0.7 | 7530 | 22 |
| pembrolizumab mode of action | 1.32 | 0.4 | 4257 | 81 |
| pembrolizumab-induced | 0.49 | 0.1 | 1420 | 41 |
| pembrolizumab in combination with | 1.84 | 0.5 | 6770 | 63 |
| does pembrolizumab cause immunosuppression | 0.62 | 1 | 4139 | 78 |
| pembrolizumab patient information leaflet | 1.36 | 0.6 | 5566 | 6 |
